Free CME from PeerView


Oncology CME

Sonia Glennie, ARNP MSN OCN AGPCNP-BC
Credits: 0.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Moving Beyond Conventional Care for DLBCL: Oncology Nurse Leadership for the Effective and Safe Use of Innovative Antibody and Cellular Therapies
Sonia Glennie, ARNP, MSN, OCN, AGPCNP-BC
September 14, 2022
Credits: 1.0 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
Alexander Drilon, MD
September 02, 2022
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Rebooting the BTK Inhibitor Sequence in MCL: Team-Centered Guidance on the Personalized Selection of Covalent and Noncovalent BTK Inhibitors in Relapsed/Refractory Disease
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Nirav Shah, MD, MS
September 02, 2022
Credits: 0.5 CME / MOC / NCPD / IPCE
PVI, PeerView Institute for Medical Education
Harmonizing Interprofessional Care With Modern, Molecularly Informed, and Equitable Therapy for Patients With Advanced Endometrial Cancer: Lessons From a Gynecologic Cancer Center of Excellence
Ritu Salani, MD, MBA
August 30, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.5 NCPD
PVI, PeerView Institute for Medical Education
Reaching the Next Level of Myeloma Patient Care: Oncology Nurse Guidance on Antibody Therapy and Novel Mechanisms of Action
Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, FAAN
August 11, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Building Real-World Bridges Between Clinicians and Patients With Myeloma: Guidance on Innovative Antibody Options
Robert Z. Orlowski, MD, PhD
July 27, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
The Path for Better Outcomes in ALL: Integrating Modern Asparaginase Compounds Into the Care of Pediatric, AYA, and Adult Patients
Prof. Carmelo Rizzari
July 19, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies: New Evidence on the Individualized Use of BTK Inhibitors in Relapsed/Refractory CLL/SLL and MCL
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Anthony R. Mato, MD, MSCE
July 15, 2022
Credits: 1.0 CME / MOC / NCPD
Penn State College of Medicine
Moving the Treatment of Advanced Gastroesophageal Cancers Forward: How Can We Maximize the Benefits of Novel Immunotherapy Approaches?
Yelena Y. Janjigian, MD
July 15, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
New Rules for BTK Inhibitors in CLL: Benchmarks for Evidence-Based Treatment Selection, Sequencing, and Safety Management
Prof. Dr. med. Stephan Stilgenbauer
July 15, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Navigating From A to B and C in Multiple Myeloma: Delivering High-Quality Care With mAbs, BCMA ADCs, and Cellular Therapy
Sagar Lonial, MD, FACP
July 12, 2022
Credits: 1.0 CME
Penn State College of Medicine
Transforming Bladder Cancer Treatment: Essential Guidance for Urologists on Therapeutic Selection, Safety, and Sequencing Along the Disease Continuum
Ashish M. Kamat, MD, MBBS
July 08, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
Jacob Sands, MD
July 04, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents
Elena Elez, MD, PhD
July 01, 2022
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Applying Therapeutic Innovations Against ALL: From Updated Evidence to Everyday Practice
Luke Maese, DO
June 30, 2022
Credits: 1.75 CME / MOC
PVI, PeerView Institute for Medical Education
Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy From Advanced to Early Disease
David P. Carbone, MD, PhD
June 28, 2022
Credits: 0.75 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Candid Conversations and Clinical Consults in Community Context: Practical Guidance for Integrating TROP2-Targeting ADCs Into Patient-Centric Breast Cancer Clinical Care
Aditya Bardia, MD, MPH
June 23, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating the Shifting Treatment Paradigm in ER+/HER2- Breast Cancer: Harnessing Modern Treatment Options and the Expanding Evidence Base to Better Patient Care and Outcomes in Early and Advanced Disease
Aditya Bardia, MD, MPH
June 16, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Making Headway Towards Better Outcomes in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Multidisciplinary Tumor Board on Implementing Novel Locoregional and Systemic Approaches
Riad Salem, MD, MBA
June 16, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Blazing the Trail Forward in the Therapeutic Management of Bladder Cancer: Expert Insights on Incorporating the Latest Evidence and Treatment Advancements Into Practice Across the Disease Continuum
Petros Grivas, MD, PhD
June 07, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Realizing the Potential of Novel Treatment Intensification Strategies for Metastatic Castration-Sensitive Prostate Cancer: The Experts’ Take on Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, Patient-Centered Care
Matthew R. Smith, MD, PhD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Immunotherapy Has Arrived in Advanced BCC: Collaborative Strategies for Making the Most of Novel Immune-Based Treatment
Karl D. Lewis, MD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Choosing Innovation With Immunotherapy in Melanoma: Guidance on Utilizing Immune-Based and Other Novel Options in Resectable and Unresectable Disease
Michael B. Atkins, MD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care
Robert I. Haddad, MD
June 05, 2022
Credits: 1.5 / MOC / NCPD
PVI, PeerView Institute for Medical Education
Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Jason Westin, MD, MS, FACP
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
The "Myelennial" Generation: Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes
Nina Shah, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Setting the Course for the Optimal Management of HCC: Improving Patient Outcomes Through the Integration of Novel Therapeutic Approaches Across the Continuum of Care
Richard S. Finn, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care
Stephen V. Liu, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Refining RCC Management Across the Disease Continuum: An Expert Clinical Consult on Leveraging New Evidence and Novel Therapeutic Strategies to Personalize Patient Care
Toni K. Choueiri, MD
June 04, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView